ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Novo Nordisk will donate a license to its library of 325,000 small molecules to the National Center for Drug Screening, an affiliate of Shanghai Institute of Materia Medica. The center will work with the World Health Organization's Special Programme for Research & Training in Tropical Diseases to screen the library for drugs that treat infectious tropical diseases including malaria, tuberculosis, and dengue fever. Novo Nordisk has discontinued research with small molecules to focus on protein-based pharmaceuticals.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter